We have reported that CM1 exerts an anti-inflammatory effect on TLR4-stimulated primary dendritic cells and mice with DSS-induced colitis and has therapeutic potential for inflammatory bowel disease [15]. The gene discussed is TLR4; the disease is inflammatory bowel disease.